Technology areas: Biotechnology & Pharmaceuticals • Transportation, E-Commerce & Mechanical Systems
4 pending office actions • 4 art units • 4 examiners • 0 of 4 (0%) have an AI response strategy ready • 9 patents granted in the last 365 days
Brandeis University has 4 pending office actions in Biotechnology & Pharmaceuticals. The matters involve 4 distinct examiners and 4 distinct art units, requiring separate tracking of technical assignments and examiner positions.
STEADMAN, DAVID J is the busiest examiner, with 1 pending matter. The recorded distribution does not identify a dominant examiner, so counsel should coordinate recurring claim and disclosure themes while tailoring each response to its own record.
Based on the USPTO statutory response window for each pending office action. 2 of the docket's apps have a known mailing date; the rest are excluded from the tile counts.
Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.
| Bucket | Cases |
|---|---|
| §101 + other | 1 (25%) |
| §112 only | 2 (50%) |
| Multi-statute (no §101) | 1 (25%) |
How the docket's pending cases split across USPTO tech-center bands.
Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.
| Examiner | Apps on this docket | Allow rate | Interview lift |
|---|---|---|---|
| STEADMAN, DAVID J | 1 | 57.7% | +29.7% |
| BERRY, LAYLA D | 1 | 66.0% | +9.0% |
| MORONEY, MICHAEL CORBETT | 1 | 24.8% | +25.0% |
| RAHMAN, MASUDUR | 1 | 72.9% | +31.7% |
Multi-statute / §101-driven matters, or cases in front of an examiner with an allow rate under 30%. The top 2 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18549945 | SYSTEMS, METHODS, AND MEDIA FOR MANAGING EDUCATION PROCESSES IN A DISTRIBUTED EDUCATION ENVIRONMENT | MORONEY, MICHAEL CORBETT | 27d |
| 18551000 | SULFUR-SUBSTITUTED SUGAR TO STABILIZE OLIGOSACCHARIDE | BERRY, LAYLA D | — |
Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 3 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18246250 | STERILE ORGANISMS, METHODS OF MAKING, AND METHODS OF USE THEREOF | RAHMAN, MASUDUR | 49d overdue |
| 18549945 | SYSTEMS, METHODS, AND MEDIA FOR MANAGING EDUCATION PROCESSES IN A DISTRIBUTED EDUCATION ENVIRONMENT | MORONEY, MICHAEL CORBETT | 27d |
| 18950126 | TETHERING CYSTEINE RESIDUES USING CYCLIC DISULFIDES | STEADMAN, DAVID J | — |
| Art Unit | Apps |
|---|---|
| 1656 | 1 |
| 1693 | 1 |
| 3628 | 1 |
| 1633 | 1 |
| App # | Title | Examiner | Art Unit | Statutes | Status | Due in | AI | Filed |
|---|---|---|---|---|---|---|---|---|
| 18950126 | TETHERING CYSTEINE RESIDUES USING CYCLIC DISULFIDES | STEADMAN, DAVID J | 1656 | §112 | Non-Final OA | — | Pending | Nov 17, 2024 |
| 18551000 | SULFUR-SUBSTITUTED SUGAR TO STABILIZE OLIGOSACCHARIDE | BERRY, LAYLA D | 1693 | §102§103§112 | Final Rejection | — | Pending | Sep 18, 2023 |
| 18549945 | SYSTEMS, METHODS, AND MEDIA FOR MANAGING EDUCATION PROCESSES IN A DISTRIBUTED EDUCATION ENVIRONMENT | MORONEY, MICHAEL CORBETT | 3628 | §101§103 | Final Rejection | 27d | Pending | Sep 11, 2023 |
| 18246250 | STERILE ORGANISMS, METHODS OF MAKING, AND METHODS OF USE THEREOF | RAHMAN, MASUDUR | 1633 | §112 | Final Rejection | 49d overdue | Pending | Mar 22, 2023 |
IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.
Start Free TrialBrandeis University has 4 pending office actions as of October 2026, spread across 4 art units and 4 examiners.
David J Steadman has the most, with 1 of Brandeis University's pending office actions.
Mostly Biotechnology & Pharmaceuticals (USPTO Tech Center 1600), based on where its pending office actions are examined.
